| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 40 |
| 1 | ASPIRIN 325 MG | 39 |
| 2 | ASPIRIN 81 MG | 39 |
| 3 | CLOPIDOGREL | 27 |
| 4 | ALENDRONATE SODIUM | 24 |
| 5 | CLOPIDOGREL BISULFATE | 20 |
| 6 | RIVAROXABAN | 19 |
| 7 | ADALIMUMAB | 18 |
| 8 | ETANERCEPT | 15 |
| 9 | GABAPENTIN | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 4 | 0.0014 |
| 1 | DICLOXACILLIN SODIUM | 1 | 0.0011 |
| 2 | FLURBIPROFEN | 1 | 0.0007 |
| 3 | PERPHENAZINE | 1 | 0.0005 |
| 4 | CLONIDINE TRANSDERMAL SYSTEM | 1 | 0.0005 |
| 5 | FERRIC CITRATE | 1 | 0.0005 |
| 6 | MECHLORETHAMINE HYDROCHLORIDE | 1 | 0.0004 |
| 7 | ERGOCALCIFEROL | 13 | 0.0004 |
| 8 | ACITRETIN | 2 | 0.0004 |
| 9 | BEMPEDOIC ACID | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 55 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 40 |
| 2 | Factor Xa Inhibitor [EPC] | 32 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 32 |
| 4 | Interleukin-23 Antagonist [EPC] | 24 |
| 5 | P2Y12 Platelet Inhibitor [EPC] | 20 |
| 6 | Endothelin Receptor Antagonist [EPC] | 17 |
| 7 | Corticosteroid [EPC] | 16 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 16 |
| 9 | Insulin Analog [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 2 | Provitamin D2 Compound [EPC] | 13 | 0.0004 |
| 3 | PCSK9 Inhibitor [EPC] | 9 | 0.0003 |
| 4 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Uric Acid-specific Enzyme [EPC] | 1 | 0.0003 |
| 6 | Interleukin-23 Antagonist [EPC] | 24 | 0.0002 |
| 7 | Antiparasitic [EPC] | 1 | 0.0002 |
| 8 | Pediculicide [EPC] | 1 | 0.0002 |
| 9 | P2Y12 Platelet Inhibitor [EPC] | 20 | 0.0002 |